<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81893">
  <stage>Registered</stage>
  <submitdate>5/03/2007</submitdate>
  <approvaldate>19/03/2008</approvaldate>
  <actrnumber>ACTRN12608000142336</actrnumber>
  <trial_identification>
    <studytitle>Acute alerting effects of daytime exposure to specific wavelengths of light</studytitle>
    <scientifictitle>The effectiveness of exposure to different colours of light in improving alertness and psychomotor vigilance in sleep restricted and non-sleep restricted healthy adult participants</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Primary health condition: Alertness and psychomotor vigilance in healthy human volunteers.</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention: Ocular exposure to specific monochromatic wavelengths of light administered using a specialised light delivery system. 
For three hours, each participant will be exposed to one of the following wavelengths of light: violet light (420nm), blue light (460nm), green light (555nm), or red light (620nm).</interventions>
    <comparator>No treatment (i.e. no exposure to light other than background room lighting)</comparator>
    <control>Placebo</control>
    <interventioncode>Behaviour</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Psychomotor Vigilance Task mean reaction time (msec).</outcome>
      <timepoint>During and immediately after light exposure, expressed relative to baseline (i.e. immediately before light exposure).</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Subjective sleepiness rating on the Karolinska Sleepiness Scale.</outcome>
      <timepoint>During and immediately after light exposure, expressed relative to baseline (i.e. immediately before light exposure).</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(1) Male and female adults aged 18 to 30 years inclusive
(2) Healthy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>30</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>(1) Individuals who have engaged in shiftwork/nightwork in the past 3 years and/or transmeridian travel in the past 3 months.
(2) Individuals who smoke, report high caffeine intake and/or high alcohol consumption. 
(3) Individuals who screen positive for drugs of abuse following comprehensive urine toxicological analysis.
(4) Women who are pregnant, lactating or planning to become pregnant during the study period. 
(5) A history of alcohol/drug dependence.
(6) Current, recent (&lt;3 months) or chronic history of use of drugs or medication that affect the central nervous system (except non-steroid topical creams, oral contraceptives and occasional use of mild pain killers.
(7) History of psychiatric illness.
(8) Recent acute or chronic medical illness.
(9) Abnormal sleep patterns/sleep disorders. 
(10) Auditory defects.
(11) Any form of photophobia including drug-induced, epilepsy, seizures, vertigo or migraine. 
(12) Individuals with diseases of the visual system. 
(13) Females who are not taking a medically approved form of birth control.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation involves contacting the holder of the allocation schedule who is off-site.</concealment>
    <sequence>Simple randomisation by using a randomisation table from a statistic book</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>21/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>3800</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Monash University</primarysponsorname>
    <primarysponsoraddress>Wellington Rd
Clayton Victoria 3800</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council</fundingname>
      <fundingaddress>Level 5
20 Allara Street
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study examines the effects of different colours of light on sleepiness and performance on various tasks. It is predicted that exposure to blue light will reduce sleepiness and improve performance more effectively than other colours of light.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alfred Hospital Human Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>5/07/2007</ethicapprovaldate>
      <hrec>109/07</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Monash University Standing Committee on Ethics in Research involving Humans (SCERH)</ethicname>
      <ethicaddress />
      <ethicapprovaldate>30/01/2007</ethicapprovaldate>
      <hrec>2006/1010</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Shantha.Rajaratnam</name>
      <address>Monash University
School of Psychology, Psychiatry and Psychological Medicine
Building 17 (PO Box 17)
Clayton Victoria 3800</address>
      <phone>+61 3 99053934</phone>
      <fax />
      <email>shantha.rajaratnam@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Shantha.Rajaratnam</name>
      <address>Monash University
School of Psychology, Psychiatry and Psychological Medicine
Building 17 (PO Box 17)
Clayton Victoria 3800</address>
      <phone>+61 3 99053934</phone>
      <fax />
      <email>shantha.rajaratnam@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>